Salty Baby
Salty Baby Overview – Sovereign Sterile Fluids Manufacturing and Contract R&D
Salty Baby is developing Australia’s first modular GMP-certified sterile fluids facility, designed to secure sovereign control over essential healthcare supplies.
The company will locally manufacture IV saline, Water for Injection (WFI), and other sterile fluids critical to hospitals, defence, and emergency services — addressing the nation’s heavy dependence on imports.
Backed by industry leaders from Pfizer, Hospira, and BioCina, Salty Baby combines pharmaceutical expertise with a capital-efficient modular design, enabling rapid scaling and reliable domestic production aligned with Australia’s sovereign manufacturing goals.
Investment Highlights
- Sovereign Supply Solution: First Australian company addressing critical dependence on imported sterile fluids.
- Large Market Gap: Australia imports over 80% of IV saline and WFI from a single overseas supplier.
- Government-Aligned: Eligible for co-funding under the National Reconstruction Fund (NRF) and state health resilience programmes.
- Confirmed Demand: Early engagement from SA Health, NSW HealthShare, WA Health, and Defence Procurement.
- Scalable Manufacturing Model: Modular GMP facility allowing rapid expansion and capital efficiency.
- Strong Margins: 70–85% gross margin potential across diversified product lines.
- De-risked Structure: Asset-backed investment with PPSR-registered security and government leverage.
- Experienced Leadership: Pharmaceutical and operational expertise from global industry veterans.
Problem and Solution
Proin auctor bibendum ex, non condimentum tortor sodales vitae. Ut feugiat at lorem accumsan consequat.
Suspendisse ac condimentum ipsum, sit amet auctor dui. Aliquam pretium justo in commodo varius.
Pellentesque elementum felis non urna vulputate, non posuere metus suscipit.
Aenean lacinia id quam a lobortis. Cras nibh lorem, vulputate eget purus elementum, pharetra condimentum elit.
Quisque et sagittis ex, vitae ultrices nulla. Vivamus dapibus blandit libero, et scelerisque dui ullamcorper ut. Vivamus ut molestie ex. Integer eget tempus mauris. Quisque volutpat pulvinar urna, posuere pharetra ex auctor vel. Sed id lacus tortor. Proin nisl turpis
Open an account to get
access to more details
Market Opportunity
Ut dignissim eget felis non ultrices. Vivamus fermentum erat at velit varius molestie.
Duis vitae mi neque.
Donec tincidunt, dolor luctus lobortis ultrices, turpis eros cursus turpis, maximus tempor lectus lectus vel diam.
Proin neque lacus, semper vel ex at, eleifend rhoncus est.
Cras non nisi urna. Sed feugiat dignissim erat, eget convallis nisl blandit a. Nullam fringilla diam eget dui
Open an account to get
access to more details
Competitive Advantage
Pellentesque tempor a risus in elementum. Proin malesuada mauris et mauris bibendum laoreet.
Vivamus maximus nulla volutpat, ornare lorem a, vulputate enim. In dui nisl, vestibulum eu finibus pretium, eleifend et eros. Vivamus in venenatis risus, ut dictum velit. Praesent rhoncus tempor fermentum. In malesuada tellus eu volutpat posuere. Nullam ut dignissim libero, ut pharetra leo. Nullam sit amet aliquam felis. Suspendisse volutpat ante eget tincidunt feugiat. Nunc placerat sapien et metus
Open an account to get
access to more details
Highlights & Milestones
Proin auctor bibendum ex, non condimentum tortor sodales vitae. Ut feugiat at lorem accumsan consequat.
Suspendisse ac condimentum ipsum, sit amet auctor dui. Aliquam pretium justo in commodo varius.
Pellentesque elementum felis non urna vulputate, non posuere metus suscipit.
Aenean lacinia id quam a lobortis. Cras nibh lorem, vulputate eget purus elementum, pharetra condimentum elit.
Quisque et sagittis ex, vitae ultrices nulla. Vivamus dapibus blandit libero, et scelerisque dui ullamcorper ut. Vivamus ut molestie ex. Integer eget tempus mauris. Quisque volutpat pulvinar urna, posuere pharetra
Open an account to get
access to more details
See more exiting opportunities on CapitalHQ
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,...
ProxyTwin
ProxyTwin™ amplifies expertise. ProxyTwin is a digital twin that works for experts so they can help more people. We create advanced digital replicas of real individuals, enabling them to virtually attend meetings, deliver messages, and hold thousands of interactions simultaneously. Recently...
HorizonTwo Capital Partners
HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.
The Insides Company
First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.
DCARB
We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.
Grabba Technologies Pty Ltd
Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.
Backed By Leading Investment Groups and Family Offices
